Molecular, Non-Invasive Wearable for Continuous Hormonal Monitoring
Harmony reads hormone activity at the molecular level, straight from the skin.
No blood draw, no clinic visit, no waiting for the next test date.
Blood tests show one frame. Harmony captures the movie.
The shift is already underway.
From invasive, episodic testing to continuous, seamless insight.
The Medical-Grade Hormonal Digital Twin.
From biology to data, continuously.
01
Hormones circulate.
Estrogen, progesterone, LH, and FSH move through the bloodstream, shifting by the hour.
03
Secretions turn volatile.
These secretions exit as volatile organic compounds (VOCs), unseen but precisely detectable.
04
The patch senses.
Harmony's patented nano-sensor array reads the VOC signature continuously, straight from the skin.
05
AI decodes signal.
Machine learning translates the pattern into continuous, quantitative hormone data.
02
Skin glands respond.
Hormones bind to receptors in the skin's glands, altering secretions according to each hormone's level.
Harmony's patch is already deployed in ongoing clinical studies, built on an active manufacturing line.
The technology adapts Harmony's core sensing platform, developed and optimized over 20 years in Professor Hossam Haick's laboratory at the Technion, into a skin-worn wearable, protected by multiple patents.
CLINICALLY DEPLOYED
ACTIVE MANUFACTURING
PATENT PROTECTED
BUILT FOR EVERY WOMAN. STARTING WITH FERTILITY CARE.
Harmony is launching first in IVF and fertility care, where hormone timing decides outcomes, and where a treatment cycle moves faster than a clinic visit can keep up with.
Fewer clinic visits.
Continuous readings replace repeated blood draws across a single cycle.
Alerts when it matters.
Meaningful hormonal shifts are flagged as they happen, not at the next scheduled test.
Less burden, less anxiety.
One wearable in place of repeated needle sticks, during an already demanding process.
Real trends, not snapshots.
Care teams see the trajectory a cycle is on, not just where it stood at one draw.
Fits existing care.
Designed to sit inside current monitoring protocols, alongside clinical judgment, not in place of it.
A Technion Spin-Out
Built to Redefine Women’s Health.
Combining clinical leadership, hands-on engineering, and 20+ years of world-leading nano-sensor research.
Dr. Zeinat Awwad, MD, MBA
Co-founder & CEO
Asaf Licht, M.Sc.
Co-founder & CTO
Prof. Hossam Haick
Co-founder & CSO
Let's talk.
Whether you run a fertility clinic, research hormones, or care for patients who could benefit from continuous hormonal monitoring, we’d love to hear from you.
Tell us who you are and what you’re working on, and our team will follow up directly.